Works in Obesity (19307381), 2023, Vol 31, Issue 1


Results: 28
    1
    2
    3

    Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics.

    Published in:
    Obesity (19307381), 2023, v. 31, n. 1, p. 111, doi. 10.1002/oby.23621
    By:
    • Lingvay, Ildiko;
    • Brown‐Frandsen, Kirstine;
    • Colhoun, Helen M.;
    • Deanfield, John;
    • Emerson, Scott S.;
    • Esbjerg, Sille;
    • Hardt‐Lindberg, Søren;
    • Hovingh, G. Kees;
    • Kahn, Steven E.;
    • Kushner, Robert F.;
    • Lincoff, A. Michael;
    • Marso, Steven P.;
    • Fries, Tea Monk;
    • Plutzky, Jorge;
    • Ryan, Donna H.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Issue Information.

    Published in:
    Obesity (19307381), 2023, v. 31, n. 1, p. 1, doi. 10.1002/oby.23209
    Publication type:
    Article